PATH

Financials

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

Address and contacts

Address (IRS master file)

437 N 34TH ST, SEATTLE, WA 98103-8601

Principal officer (990 for 2025)

OLEG SOLOVEY, 437 N 34TH STREET, SEATTLE, WA 98103

Signed the 990

OLEG SOLOVEY, CONTROLLER

Phone

(206) 285-3500

Website

WWW.PATH.ORG

Return prepared by

GELMAN ROSENBERG & FREEDMAN

Mission

PATH MAKES GOOD HEALTH MORE ACCESSIBLE IN 70+ COUNTRIES BY IMPROVING THE HEALTH CARE PEOPLE RECEIVE, CREATING AFFORDABLE HEALTH PRODUCTS, AND ADVANCING EFFECTIVE HEALTH POLICIES. ACROSS ALL OUR PROJECTS AND PROGRAMS, (CONTINUED ON SCHEDULE O)PATH REACHED MORE THAN 116 MILLION PEOPLE WITH QUALITY HEALTH CARE IN 2025.

Program accomplishments

• PATH'S PRODUCT DEVELOPMENT DIVISION ENSURES THAT THE RIGHT HEALTH PRODUCTS REACH THE PEOPLE WHO NEED THEMAFFORDABLY AND EFFECTIVELY. WE DEVELOP VACCINES, DIAGNOSTICS, MEDICAL DEVICES, AND DRUG FORMULATIONS FOR LOW-RESOURCE SETTINGS, FROM EARLY-STAGE RESEARCH THROUGH LICENSURE, QUALITY TESTING, AND INTRODUCTION. AS A PRODUCT DEVELOPMENT PARTNERSHIP, WE ACT AS THE GLUECONNECTING PRIVATE-SECTOR MANUFACTURERS, NATIONAL HEALTH PROGRAMS, AND COMMUNITIES. WE ENSURE LIFESAVING HEALTH PRODUCTS ARE DESIGNED FOR REAL-WORLD CONDITIONS SO THEY CAN REACH EVERYONE WHO NEEDS THEM.(CONTINUED ON SCHEDULE O)2025 ACHIEVEMENTS INCLUDE, BUT ARE NOT LIMITED TO:- ADVANCING HPV VACCINE RESEARCHPATH INITIATED A PHASE 3 STUDY TO COMPARE INNOVAX'S NINE-VALENT HUMAN PAPILLOMAVIRUS (HPV) VACCINE WITH GARDASIL 9 USING A SINGLE-DOSE REGIMEN, WITH THE GOAL OF ADDING ANOTHER NINE-VALENT PRODUCT TO THOSE RECOMMENDED FOR USE ON A SINGLE-DOSE SCHEDULE.- TCV INTRODUCTIONSPATH, AS PART OF THE TYPHOID VACCINE ACCELERATION CONSORTIUM, SUPPORTED THREE NATIONAL TYPHOID CONJUGATE VACCINE (TCV) INTRODUCTIONS THAT REACHED 10.5 MILLION IN BURKINA FASO, 21 MILLION IN KENYA, AND 44 MILLION IN BANGLADESH. RESULTS FROM THE PATH-SPONSORED PHASE 3 STUDY OF THE EUBIOLOGICS CO., LTD TCV PRODUCT THAT ENABLED NATIONAL LICENSURE WERE PUBLISHED AND FORMED A CRITICAL PART OF THE DATA PACKAGE FOR WORLD HEALTH ORGANIZATION (WHO) PREQUALIFICATION, WHICH, IF APPROVED, WILL FURTHER INCREASE AVAILABILITY AND ACCESS TO TCV.- EPIDEMIC PREPAREDNESSMANAGED BY PATH, THE RNA COOPERATIVE LAUNCHED IN JUNE 2025 TO STRENGTHEN THREE LOW- AND MIDDLE-INCOME COUNTRY MANUFACTURERS' FOUNDATIONAL RNA VACCINE DEVELOPMENT AND MANUFACTURING CAPACITY. PATH ALSO BECAME THE TECHNICAL COORDINATING PARTNER OF THE RESEARCH PREPAREDNESS PROGRAM IN EAST AND CENTRAL AFRICA TO BOLSTER LOCAL CLINICAL TRIAL CAPACITY AND DISEASE OUTBREAK READINESS. ADDITIONALLY, PATH BEGAN NEWLY FUNDED WORK ON A CORRELATES OF PROTECTION PLAYBOOK TO ACCELERATE THE DEVELOPMENT OF VACCINES AGAINST FILOVIRUSES.- SAFER MALARIA TREATMENT WITH G6PD TESTINGPATH HELPED CO-DEVELOP THE FIRST POINT-OF-CARE TEST FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY TO RECEIVE WHO PREQUALIFICATION. THE STANDARD G6PD TEST USES A SIMPLE FINGER PRICK AND DELIVERS RESULTS IN UNDER TWO MINUTES, PROVIDING A SAFER TREATMENT OF PLASMODIUM VIVAX (P. VIVAX) MALARIA AND REDUCING THE RISK OF DANGEROUS DRUG REACTIONS, ESPECIALLY FOR WOMEN WITH INTERMEDIATE DEFICIENCY LEVELS. IN ETHIOPIA AND VIETNAM, PATH SUPPORTED THE IMPLEMENTATION OF G6PD-TEST-FACILITATED SAFER TREATMENT OF P. VIVAX MALARIA, WITH A NEW SINGLE-DOSE DRUG.- REDUCING HEALTH CARE-ASSOCIATED INFECTIONS A MULTIYEAR COLLABORATION BETWEEN PATH, THE UGANDA MINISTRY OF HEALTH, GHANA HEALTH SERVICE, AND AQUA RESEARCH, LLC RESULTED IN THE FORMAL ADOPTION OF THE AQUA RESEARCH STREAM DISINFECTANT GENERATOR INTO GHANA AND UGANDA'S PUBLIC HEALTH SYSTEMS. THE DEVICE ENABLES STAFF TO GENERATE HIGH-QUALITY CHLORINE ON-SITE WITH THE PUSH OF A BUTTON FOR DISINFECTION AND INFECTION PREVENTION AND CONTROL.
  Expenses $115,137,501 · grants $35,903,295
• PATH'S GLOBAL HEALTH PROGRAMS DIVISION WORKS IN PARTNERSHIP WITH GOVERNMENTS AND COMMUNITIES TO TURN PROVEN HEALTH INNOVATIONS INTO REAL-WORLD SOLUTIONS THAT REACH THE PEOPLE WHO NEED THEM MOST. WE STRENGTHEN PRIMARY HEALTH CARE SYSTEMS BY EXPANDING ACCESS TO LIFESAVING TOOLS, INCLUDING MALARIA PREVENTIVES AND HIV SERVICES. WE PRIORITIZE BUILDING EVIDENCE, IMPROVING EFFICIENCY, AND SUPPORTING LOCAL HEALTH WORKERS OFTEN USING DIGITAL TOOLS, STRENGTHENED SURVEILLANCE SYSTEMS, AND DATA TO GUIDE SMARTER DECISIONS. WE EQUIP HEALTH SYSTEMS TO PERFORM BETTER, FASTER, AND MORE RELIABLY. OUR GOAL IS INTEGRATED, PERSON-CENTERED CARE THAT SPANS DISEASES AND GEOGRAPHIES, MAKING CARE MORE ACCESSIBLE, EFFECTIVE, AND ALIGNED WITH THE NEEDS OF THE PEOPLE IT SERVES. (CONTINUED ON SCHEDULE O)2025 ACHIEVEMENTS INCLUDE, BUT ARE NOT LIMITED TO:- MALARIA PREVENTION AND SURVEILLANCEPATH'S MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA V) PROVIDED TECHNICAL SUPPORT ACROSS SEVEN COUNTRIES' NATIONAL MALARIA PROGRAMS TO ADVANCE PRIORITIES IN SURVEILLANCE, COMMUNITY CASE MANAGEMENT, DATA USE, AND STRATEGIC PLANNING. THROUGH THE REACHING EVERY AT-RISK COMMUNITY AND HOUSEHOLD WITH MALARIA SERVICES (REACH MALARIA) PROJECT, PATH SUPPORTED SEASONAL PREVENTION CAMPAIGNS THAT REACHED 2.9 MILLION CHILDREN WITH LIFESAVING MEDICINE. THE PROJECT ALSO PARTNERED WITH NATIONAL PROGRAMS IN 22 COUNTRIES TO STRENGTHEN SERVICE DELIVERY AND IMPROVE THE QUALITY OF CARE.AS PART OF THE ROTARY HEALTHY COMMUNITIES CHALLENGE, PATH SUPPORTED INTEGRATED COMMUNITY CASE MANAGEMENT IN NIGERIA AND PROVIDED TECHNICAL ASSISTANCE FOCUSED ON MONITORING AND DATA USE IN THE DEMOCRATIC REPUBLIC OF THE CONGO, MOZAMBIQUE, AND ZAMBIA. - STRENGTHENING PRIMARY HEALTH CAREPATH'S PRIMARY HEALTH CARE PROGRAM STRENGTHENED SUSTAINABLE, PEOPLE-CENTERED, INTEGRATED PRIMARY HEALTH CARE PLATFORMS ACROSS 41 COUNTRIES, REACHING OVER 40 MILLION PEOPLE WITH ESSENTIAL HEALTH CARE. THIS INCLUDES MATERNAL AND CHILDHOOD IMMUNIZATION, WOMEN'S ACCESS TO INJECTABLE CONTRACEPTION, FACILITATION OF HIV AND TUBERCULOSIS (TB) TESTING AND CARE SERVICES, AND ACCESS TO SCREENING, PREVENTION, AND CARE SERVICES FOR NONCOMMUNICABLE DISEASES. - OXYGEN THERAPY AND EQUIPMENT ACCESSTO ADDRESS GAPS IN OXYGEN ACCESS, PATH ESTABLISHED THE OXYGEN DELIVERY GAP FUND TO IDENTIFY AND PROCURE ESSENTIAL CONSUMABLES, ACCESSORIES, AND DEVICES NEEDED TO KEEP OXYGEN FLOWING. THROUGH THIS EFFORT, PATH PROCURED 119,101 PRODUCTS ACROSS FIVE AFRICAN COUNTRIES, ENABLING 790,000 PATIENTS ANNUALLY TO HAVE ACCESS TO OXYGEN DELIVERY SYSTEMS. WORKING IN CLOSE PARTNERSHIP WITH NATIONAL CIVIL SOCIETY AND COMMUNITY ACTORS, PATH LAUNCHED THREE LOCALLY LED ADVOCACY COALITIONS IN KENYA, MALAWI, AND TANZANIA. THESE COALITIONS HELP MOBILIZE LOCAL CHAMPIONS AND CROSS-SECTORAL COLLABORATION TOWARD SUSTAINABLE OXYGEN ECOSYSTEMS.
  Expenses $106,767,987 · grants $25,799,147
• IN THE ASIA, MIDDLE EAST, AND EUROPE (AMEE) REGION, WE PARTNER WITH COUNTRIES TO TACKLE URGENT HEALTH CHALLENGES AND EXPAND ACCESS TO CARE. WE WORK AT EVERY LEVEL, FROM COMMUNITIES TO NATIONAL GOVERNMENTS, BRINGING SCIENCE, TECHNOLOGY, AND PARTNERSHIPS CLOSER TO WHERE CHANGE HAPPENS. FROM EXPANDING TYPHOID VACCINATION IN BANGLADESH TO IMPROVING HIV SERVICES IN UKRAINE, WE TAILOR OUR SOLUTIONS TO LOCAL NEEDS AND BUILD RESILIENT, SUSTAINABLE HEALTH SYSTEMS. 2025 ACHIEVEMENTS INCLUDE, BUT ARE NOT LIMITED TO:- BANGLADESHPATH SUPPORTED THE DELIVERY AND MONITORING OF TYPHOID VACCINATION CAMPAIGNS TO IMPROVE COVERAGE AND SAVE LIVES. (CONTINUED ON SCHEDULE O)- CAMBODIAPATH CONTINUED WORKING WITH THE GOVERNMENT OF CAMBODIA TO BUILD A SUSTAINABLE ONE HEALTH ARCHITECTURE THAT ENABLES EVIDENCE-BASED DECISION SUPPORT FOR THE PREVENTION, EARLY DETECTION, AND RESPONSE TO INFECTIOUS DISEASES.- CHINAPATH CONTINUED TO ADVANCE THE DEVELOPMENT OF TECHNOLOGIES, INCLUDING DIAGNOSTIC TOOLS FOR TB, HPV, POLIO, AND ROTAVIRUS VACCINES. THE WHO-PREQUALIFIED BIVALENT HPV VACCINE (SUPPORTED BY PATH) WAS INTRODUCED IN CHINA'S NATIONAL IMMUNIZATION PROGRAM.- INDIAPATH ADVANCED MEDICAL OXYGEN SYSTEMS FOR NEWBORN SURVIVAL AND ENGAGED YOUTH FOR IMPROVING TB DIAGNOSIS AND TREATMENT AND GENERATING AWARENESS OF ANTIMICROBIAL RESISTANCE. PATH WORKED TO STRENGTHEN SUPPLY CHAINS FOR IMPROVED ACCESS TO HEALTH PRODUCTS, CREATED DIGITAL HEALTH ROADMAPS, SUPPORTED THE ROLLOUT OF ARTIFICIAL INTELLIGENCEBASED DIAGNOSTIC TOOLS, AND STRENGTHENED INTEGRATED DISEASE SURVEILLANCE OF ACUTE ENCEPHALITIS SYNDROME.- INDONESIAPATH INTRODUCED TOOLS FOR IMPROVING THE CAPACITY OF HEALTH WORKERS TO DELIVER PRIMARY HEALTH CARE AND WORKED WITH THE MINISTRY OF HEALTH TO CONVENE PRIVATE-SECTOR PARTNERS (VACCINES, THERAPEUTICS, AND DIAGNOSTICS) AND STRENGTHEN HEALTH ARCHITECTURE FINANCING AND REGIONAL MANUFACTURING.- MYANMARPATH CONTINUED TO STRENGTHEN TB AND PERINATAL MENTAL HEALTH SERVICES. - PAKISTANPATH SUPPORTED THE CREATION OF A RESULTS FRAMEWORK TO EVALUATE A MULTISECTORAL NUTRITION PROGRAM.- UKRAINEPATH SUPPORTED THE EXPANSION OF NATIONAL E-HEALTH SERVICES AND DELIVERY OF HIV, TB, AND MATERNAL MENTAL HEALTH SERVICES IN WAR-AFFECTED AREAS.- VIETNAMPATH STRENGTHENED ANTIMICROBIAL RESISTANCE SURVEILLANCE, OXYGEN UTILIZATION, AND RESPIRATORY CARE ECOSYSTEMS. PATH ALSO STRENGTHENED ROUTINE IMMUNIZATION SYSTEMS IN SON LA AND IMPROVED WORKPLACE HEALTH AND SAFETY BY IMPROVING WORKER WELL-BEING AND OCCUPATIONAL HEALTH CAPACITY.
  Expenses $33,482,517 · grants $5,363,501
• AFRICA REGIONIN THE AFRICA REGION, WE PARTNER WITH COUNTRIES TO DELIVER HEALTH PROGRAMS THAT RESPOND TO LOCAL PRIORITIES, FROM MALARIA AND HIV TO VACCINES, EPIDEMIC PREPAREDNESS AND RESPONSE, AND DIGITAL HEALTH AND ARTIFICIAL INTELLIGENCE. WE WORK AT EVERY LEVEL, FROM COMMUNITIES TO NATIONWIDE PROGRAMS, STRENGTHENING EXISTING HEALTH SYSTEMS RATHER THAN CREATING NEW ONES. OUR FOCUS IS ON SUSTAINABILITY AND IMPACT, WHILE OPTIMIZING OPERATIONS AND STAFF SUPPORT. BY COMBINING LOCAL INSIGHT WITH GLOBAL INNOVATION, WE HELP BUILD RESILIENT HEALTH SYSTEMS AND IMPROVE LIVES. 2025 ACHIEVEMENTS INCLUDE, BUT ARE NOT LIMITED TO: - MOZAMBIQUEPATH SUPPORTED THE SCALE-UP OF SELF-INJECTABLE CONTRACEPTIVES ACROSS 143 HEALTH FACILITIES IN SOUTHERN MOZAMBIQUE, REACHING MORE THAN 63,000 CONTRACEPTIVE VISITS AND EXPANDING WOMEN'S ACCESS TO FAMILY PLANNING.- NIGERIAPATH HELPED STRENGTHEN COMMUNITY-BASED HEALTH CARE IN NIGERIA BY TRAINING MORE THAN 700 COMMUNITY HEALTH WORKERS IN 2025 TO EXPAND ACCESS TO EARLY DIAGNOSIS AND TREATMENT.- TANZANIAPATH HELPED IMPLEMENT A BIOMETRIC FINGERPRINT SYSTEM ACROSS APPROXIMATELY 3,600 HEALTH FACILITIES IN TANZANIA, IMPROVING CONTINUITY OF HIV CARE THROUGH SECURE PATIENT IDENTIFICATION. - MULTICOUNTRYPATH SUPPORTED MALARIA VACCINE ROLLOUT ACROSS EIGHT COUNTRIES, HELPING MINISTRIES OF HEALTH PLAN, INTRODUCE, AND DELIVER VACCINES TO MILLIONS OF CHILDREN IN HIGH-BURDEN SETTINGS. PATH SUPPORTED A DIGITAL COLD CHAIN MONITORING SYSTEM BUILT ON THE NATIONAL DHIS2 PLATFORM IN SENEGAL, HELPING ENSURE VACCINES REMAIN SAFE AND EFFECTIVE THROUGH REAL-TIME TEMPERATURE MONITORING. OTHER: ADVOCACY AND PUBLIC POLICYAT PATH'S CENTER FOR ADVOCACY AND PUBLIC POLICY, WE WORK TO ENSURE EVERYONE CAN ACCESS THE HEALTH SERVICES AND INNOVATIONS THEY NEED TO THRIVE. WE PARTNER WITH POLICYMAKERS IN COUNTRIES SUCH AS KENYA, SOUTH AFRICA, AND THE UNITED STATES AND ON THE GLOBAL STAGE TO DRIVE INVESTMENTS AND POLICIES THAT SUPPORT PRIMARY HEALTH CARE, MATERNAL AND CHILD HEALTH, IMMUNIZATION, AND INNOVATION. WE ALSO SUPPORT LOCAL ADVOCACY PARTNERS BY TRANSLATING EVIDENCE INTO CLEAR MESSAGES, BUILDING COALITIONS, AND SHARING KNOWLEDGE. IN 2025, OUR EFFORTS LED TO NEW POLICIES, INCREASED FUNDING, AND STRONGER LOCAL CAPACITY TO SHAPE HEALTH AGENDAS AND IMPROVE HEALTH SYSTEMS AROUND THE WORLD. 2025 ACHIEVEMENTS INCLUDE, BUT ARE NOT LIMITED TO: - EXPANDING ACCESS TO LIFESAVING HEALTH PRODUCTS AND SERVICES IN AFRICAPATH SUPPORTED KENYA TO DEVELOP ITS FIRST LOCAL HEALTH PRODUCTS MANUFACTURING POLICY, A KEY STEP IN ADVANCING REGIONAL SELF-RELIANCE.PATH HELPED DRIVE PROGRESS TOWARD A UNIFIED REGULATORY ENVIRONMENT BY SUPPORTING TWO ADDITIONAL COUNTRIES TO RATIFY THE AFRICAN MEDICINES AGENCY TREATY. IN KENYA, PATH WORKED WITH THE NATIONAL GOVERNMENT TO PILOT A TOOL TO MEASURE THE EFFECTIVENESS OF ITS NEW PRIMARY HEALTH CARE NETWORK SYSTEM. IN NYAMIRA COUNTY, WE SUPPORTED DEVELOPMENT AND ADOPTION OF A LAW TO PROTECT FUNDING FOR HEALTH PRODUCTS AND TECHNOLOGIES. TO ADVANCE MATERNAL, NEWBORN, AND CHILD HEALTH AND IMMUNIZATION IN AFRICA, PATH LED CO-CREATION EFFORTS WITH KEY REGIONAL AND GLOBAL PARTNERS, RESULTING IN UNIFIED ADVOCACY STRATEGIES TO GUIDE PARTNER EFFORTS.
  Expenses $34,791,873 · grants $6,109,653

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

IRS record

EIN

91-1157127

Tax-exempt status

501(c)(3): Charitable, religious, educational or scientific organization

Foundation status

Publicly supported organization (170(b)(1)(A)(vi))

Donations deductible (Pub 78)

Public charity, 50% deduction limit

Exempt since

1982

Accounting year ends

December

Files

Form 990 or 990-EZ

Category (NTEE)

International, foreign affairs and national security (Q300)

Assets (IRS master file)

$382,170,085

Income (IRS master file)

$393,052,890

Filing history

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 91-1157127).

Questions about PATH

What is the EIN of PATH?

The employer identification number (EIN) of PATH is 91-1157127.

Is PATH tax-exempt?

Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1982.

Are donations to PATH tax-deductible?

Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).

Which annual return does PATH file?

Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.

When is the next return of PATH due?

The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.

When did PATH last file with the IRS?

The latest return in the IRS public files is the 990 for the year ended December 2025.

Who is the principal officer of PATH?

The 990 for the year ended December 31, 2025 names OLEG SOLOVEY.

Who are the officers and directors of PATH?

The 990 for the year ended December 31, 2025 lists 31 people; 15 received compensation from the organization, the highest $632,113 (NIKOLAJ JESTED GILBERT MSC, PRESIDENT AND CEO).

How much revenue does PATH have?

On its 990 for the year ended December 31, 2025 it reported revenue of $321,942,685, expenses of $320,553,095 and total assets of $382,170,085 at year end.

Other nonprofits in SEATTLE

• PANORAMA GLOBAL
  EIN 81-4204119 · last filed 990 for 2024
• AGROS INTERNATIONAL
  EIN 91-1276578 · last filed 990 for 2024
• ASHESI UNIVERSITY FOUNDATION
  EIN 91-1997089 · last filed 990 for 2024
• PEACETREES VIETNAM
  EIN 20-1051471 · last filed 990 for 2024
• EARTHCORPS
  EIN 91-1592071 · last filed 990 for 2024
• NA AH ILLAHEE FUND
  EIN 05-0630992 · last filed 990 for 2024
• AMIGOS DE HONDURAS
  EIN 91-1638574 · last filed 990 for 2024
• UPAYA SOCIAL VENTURES
  EIN 80-0713334 · last filed 990 for 2024

All nonprofits in SEATTLE · Washington · International, foreign affairs and national security